Plethora Solutions Holdings
James Mellon has been appointed as a non-executive director of the urological products developer. Mellon started his career with GT Management, and later became the co-founder and managing director of Thornton Management (Asia), based in Hong Kong. He is also co-founder of Regent Pacific Group and Charlemagne Capital, chairman of Manx Financial Group, Speymill and Rivington Street Holdings, and co-chairman of Regent Pacific Group and West African Minerals Corporation.

Old Mutual
Old Mutual has appointed Ian Gladman as group strategy director. Gladman, who will be a member of the group’s executive committee, previously worked at UBS Investment Bank where he spent 16 years, most recently as co-head of financial institutions, EMEA, covering a range of UK and European insurance companies, banks and asset managers.

Barclays Wealth
The wealth manager has appointed Paul Fleming as director, head of strategic partnerships to work across the UK & Ireland private bank, international private bank and the wealth advisory division, based in London. Fleming joins Barclays Wealth from PwC, where he was most recently head of strategic partnerships.

Lloyds Pharmacy
The pharmacy chain has appointed Phil Streatfield to the board-level position of supply chain and business efficiency director. He joins from Spicers Europe, where he was European supply chain and IT director.

MGM Advantage
The retirement income specialist has appointed Jim Roberts as a non-executive director and chairman of the investment committee. Roberts spent 26 years at Skandia Group, including positions as appointed actuary, finance director and group investment director.

Bryan, Garnier AM
Bryan, Garnier Asset Management has appointed Steve Wallace as managing director responsible for commercial activities and will be part of the senior management team and investment committee, based in London.

Alliance Trust
Karin Forseke has been appointed as non-executive chairman to succeed Lesley Knox. Forseke will join the board of the company on 1 March and will become chairman on 2 April. Forseke holds a number of non-executive directorships, including deputy chairman and senior independent director of the FSA and a non-executive director of Wallenius Lines AB. Previous roles include CEO of D Carnegie & Co AB and COO of the London International Financial Futures and Options Exchange.